SOURCE: Industry Standard Research

Industry Standard Research

January 28, 2015 09:46 ET

MPI Research, BioReliance Among Top Performers in ISR's Inaugural Preclinical CRO Quality Benchmarking Study

Informing the Drug Development and Commercialization Industry

CARY, NC--(Marketwired - January 28, 2015) - Industry Standard Research (ISR) has announced the availability of a new report titled, "CRO Quality Benchmarking -- Preclinical Service Providers." This report provides a Consumer Reports-style analysis of 446 service encounters across 42 preclinical CROs.

"Each of these preclinical CROs was evaluated across 22 service quality attributes," explained Kevin Olson, CEO of Industry Standard Research. "From these evaluations, the respondents have indicated there are several high performing providers, two of which particularly stand out, MPI Research and BioReliance. Both of these providers rank among the top performers for several of the attributes rated as most important by survey respondents. These include: Therapeutic Expertise, Scientific Knowledge, Data Quality Metrics, and Experience Conducting Specific Tests and Assays," continued Olson.

The report also addresses market conditions for preclinical activities. "Overall, growth in outsourced preclinical services appears strong," stated Olson. "Providers should anticipate overall growth in the mid-single digits." The report provides individual growth figures for 9 specific preclinical services including: Analytical Methods (Chemistry), Animal Models, In Vitro ADME Studies, In Vivo ADME Studies, Pharmacodynamics, Pharmacokinetics, Preformulation, Safety Pharmacology, and Toxicology.

Without prior experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased assessments of CRO performance passed on through word of mouth from peers within the industry. In this Benchmarking report, ISR provides the data necessary to make smarter, more informed, confident decisions and provides CROs the ability to understand their competitive strengths and weaknesses to better meet customer needs going forward.

CROs included in this report:

  • Absorption Systems
  • Accelera
  • Alliance Pharma Inc.
  • Aptiv Solutions
  • Aptuit
  • Avanza Laboratories
  • BASi
  • BioDuro
  • BioReliance
  • BRI Biopharmaceutical Research
  • Calvert
  • CeeTox
  • Cellular Technology Limited (CTL)
  • Charles River Laboratories
  • CiToxLab
  • Covance
  • EMD Millipore
  • Frontage Laboratories
  • Harlan
  • Huntington Life Sciences
  • IITRI
  • Indivumed GmbH
  • Maccine
  • MD Biosciences
  • MDS Pharma
  • MicroConstants
  • MPI Research
  • Myriad RBM
  • Quotient BioResearch
  • Ricerca
  • Sequani
  • Sirius Analytical
  • SNBL
  • Southern Research
  • SRI International, Biosciences Division
  • Taconic
  • Toxicon
  • Wil Research
  • William Harvey Research
  • WuXi AppTec
  • XenoBiotic Laboratories
  • XenoTech

For more information about ISR's "CRO Quality Benchmarking -- Preclinical Service Providers" report, please visit the report page at: http://www.isrreports.com/product/cro-quality-benchmarking-preclinical-service-providers/

For more information about ISR's Phase I, II/III, IV, and CMO Quality Benchmarking reports please visit ISR's website at: http://www.isrreports.com/product-category/cro-and-service-provider-benchmarking-reports/

About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit the company's website at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.

Contact Information